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Aim. To study the association of the polymorphic variants of ACE (I/D), AT2R1 (A1166C), TNF-á (G308A),
MTHFR (C677T) genes and their combinations with the risk of perinatal pathology and gestation reduction.
Methods. The polymorphic variants of genes were analyzed by PCR and RFLP in 235 newborns with severe
perinatal pathology and 110 clinically healthy term newborns. Results. An increased risk of severe perinatal
pathology was associated with such genotypes: DD and ID (ACE), 1166AC, 1166CC (AT2R1), 677CT
(MTHFR), 308AA and 308AG (TNF-α), this risk  for homozygotes is almost 2-fold higher than for heterozygotes. 
Reduction of terms of gestation is associated with the genotype 677TT (MTHFR), and resistance to diseases in
the perinatal period – with the genotype II (ACE) and 1166AA (AT2R1), 677CC (MTHFR) and the 308GG (TNF-
α), particularly when com- bined. Conclusions. The identified associations evidence the role of polymorphic
variants of ACE, AT2R1, TNF-α, MTHFR genes in the development of severe perinatal pathology and can be
used for its early prediction   with subsequent correction of treatment.
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 Introduction. Perinatal pathology of newborns is a
current   interdisciplinary problem of modern clinical
medicine as it contributes significantly to the infant
mortality and incapacitation, increasing both. In
perinatal period, which covers antenatal life from week
28 of gestation throughout the first week after birth, in
organisms of both fetus and newborn experience some
important physiological processes occur aimed at
preparation and adaptation to the postnatal life. Quite
often these physiological processes are accompanied
by the development of pathologies. Perinatal pathology 
is diagnosed in the newborns, who suffered from
perinatal asphyxia and showed clinical symptoms of
hypoxic and ischemic brain damage, revealed through
the analysis of clinical symptoms and the presence of
perinatal risk factors. As for today, there are neither
laboratory tests nor methods enabling clear forecast or
diagnosis and determination of the severity degree.
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The role of genetic factors in the development and
course of critical conditions of newborns is studied
insufficiently. Scientific literature contains
disembodied data about the influence of genetic
polymorphism and mutations on the risk of
development of perinatal pathology and neonatal
syndromes [1–5]. There has never been complex study
on polymorphic variants of genes and their
combinations in view of pathogenic mechanisms of the
development of critical conditions in newborns. For
that reason the objective of our research was to study 
association of polymorphic variants of genes of
angiotensin-converting enzyme (ACE (I/D)), receptor
of angiotensin II type 1 (AT2R1 (A1166C)), tumor
necrosis factor (TNF-á (G308A)),
methylentetrahydrofolate reductase (MTHFR
(C677T)) and their combinations with the risk of
development of perinatal pathology and reduction in
gestation terms.
Materials and Methods.Two hundred and thirty
five newborns, 1–3 days old, with severe perinatal
pathology, admitted to the specialized Department of
Pathology of Newborns of OKHMADET, Science and
Research Specialized Hospital, Kyiv, and Department
of Intensive Therapy of Maternity Home, Poltava, were 
examined. 119 newborns with severe perinatal
pathology were born with gestation age of 28–37
weeks, 116 newborns – 38–40 weeks. Throughout the
early neonatal period all 235 newborns showed clinical
symptoms of perinatal hypoxic and ischemic damage
of nervous system, which in 201 newborns (85.53%)
was caused by perinatal asphyxia. Out of total of 235,
151 newborns (64.26%) showed the complication of
early perinatal period by respiratory distress syndrome
(RDS), 69 newborns (29.36%) had necrotic
enterocolitis (NEC), 84 newborns (35.74%) had
neonatal jaundice. A criterion for the newborn to be
studied was the presence of severe perinatal pathology,
while congenital malformation, development
anomalies, and hereditary diseases were the criteria for
exclusion. Standard clinical, instrumental, and
laboratory methods were applied by neonatologists in
specialized departments to determine the diagnosis.
Control group included 110 clinically healthy
newborns, born during term labors or physiological
labors (Apgar score 8-9) without clinical symptoms of
perinatal diseases and let home on 3rd–5th day. DNAs
were isolated from newborns’ cord and peripheral
blood using DNA-sorb-B reagents (Russian
Federation) according to the manufacturer’s
instructions. Polymorphic variants of ACE (I/D),
AT2R1 (A1166C), TNF-á (G308A), MTHFR (C677T)
genes were analyzed using the method of polymerase
chain reaction (PCR) and restriction fragment length
polymorphism (RFLP) [6–8]. The amplification
conditions and list of restriction endonucleases are
presented in Table 1. Depending on the
presence/absence of certain restriction sites in the
amplified DNA section, the restriction products varied
in length (Table 1). The PCR and RFLP products were
detected in 2% agarose gel. The length of restriction
fragments was analyzed against a marker DNA.
Statistic analysis of results was made using
Statistica 6 software to calculate standard criterion ÷2
and to define Odds Ratio (OR).
Results and Discussion. While planning this
study, we selected some possible candidate genes in
accordance with the current views about mechanisms
of the development of perinatal pathologies. Analysis
of specificities of metabolic processes in fetuses and
newborns throughout perinatal period enabled us to
distinguish principal pathogenic links, subjected to
pathological changes at the development of critical
conditions, as well as possible susceptibility-associated 
genes, presented in Figure 1.
Supporting appropriate level of blood circulation
and vascular homeostasis processes is extremely
important at the maximal tension of physiological
processes during the delivery and adaptation in early
neonatal period. The ACE and AT2R1 gene expression
products are involved into stabilization of vascular and
cell homeostasis, functional state of endothelium, and
blood circulation processes [9, 10]. According to the
scientific literature data, deletion polymorphism of
ACE gene (DD-genotype) is known to be associated
with an increase in ACE activity, which enhances the
tonus of smooth vascular muscles and susceptibility to
acute ischemia [11]. Some authors supposed that
regulation of soluble ACE level could be connected
with disorder in the regulation of transcription or
splicing of ACE pre-mRNA. As a rule, the presence of
genotype II has protective effect on cardiovascular
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events due to the fact that low enzymatic activity does
not lead to activation of angiotensin II and inactivation
of bradykinin. The AT2R1 activity also influences the
occurrence of dysfunction of vascular endothelium.
The carriers of different genotypes of AT2R1 gene
differ in efficiency of binding angiotensin II, which
defines functional condition of a blood vessel wall.
Scientific literature contains the data about
sinergistical impact of AT2R1 1166CC genotype and
ACE DD genotype on the development of pathological
changes in cardiovascular system [11].
The above mentioned mechanisms of support of
vascular homeostasis are extremely important for
newborns as in perinatal period normal blood
circulation is essential in the conditions of short and
long term hypoxia as well as in case of resuscitation in
critical conditions.
Necessary physiological reorganization of
newborn requires optimal metabolic transformations
taking into account the fact that occurring hypoxia
leads to the imbalance of oxidative and antioxidative
processes, which, in its turn, stimulates the synthesis of
anti-inflammatory cytokines and assists in changing
vascular homeostasis.
Activation of vascular cytokines, including TNF-á, 
is a response to many stimuli, i.e. hypoxia, intrauterine
infection, birth stress [12]. It has been shown that for
individuals with AA genotype in 308th position of
promoter area of TNF-á gene the transcriptional
activity of the latter is higher [13], i.e.
anti-inflammatory cytokine in these individuals is
synthesized in inadequately increased amounts, and it
influences rapid increase in the formation of hydrogen
peroxide and other free radicals in macrophages and
neutrophils, which results in significantly higher
oxidative stress. Accordingly, the individuals with
308GG genotype have normal transcriptional activity
of the gene, which does not lead to excessive
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Gene
Amplification conditions
Restriction endonuclease Polymorphism
Length of fragments after 
amplification and
restriction, b.p.Annealing, °Ñ No. of cycles
ACE 58 30 – I/D 490, 190
AT2R1 65 35 BstDeI A1166C 352, 238 è 114 
MTHFR 70 35 HinfI C677T 301, 176 è 125 
TNF-α 60 35 NcoI G308A 107, 87 è 20
Table1
Conditions for definition of polymorphic variants of studied genes
TNF-a
IL6
IL1 0
AGT 
ACE
AT2R1
MTHFR
NAT2
GS Ts
Perin ata l
pa th ology
blood circulation
Va scular  ho meos ta sis
Detoxicatio n
Vitamins  a nd  microelements accumulation
an d their metabo lism
An tioxidant pro tection
M acrop hages activations
Development of the inflammatory response
Fig. 1 Possible candi-
date genes, associated
with newborns’ here-
ditary susceptibility to
perinatal pathology
production of TNF-á cytokine. The newborns with AA
genotype responding to unfavorable course of perinatal 
period or birth stress will hyperproduce
anti-inflammatory cytokine TNF-á, which causes
irreversible changes accommodating perinatal hypoxic 
damage, cardiovascular disorders and apoptosis.
Missense mutation C677T in MTHFR gene
decreases catalytic activity of corresponding enzyme
by average 35-70% of norm by changing its
thermolability. A number of polymorphic MTHFR
variants were shown to influence the process of
apostasies of chromosomes and antenatal development
[14]. Thus, genotypes 677CT and 677TT are associated 
with the development of defects and other disorders in
fetus as a result of occurring deficit of methyl groups,
which are necessary for cell proliferation and
differentiation, as well as for an increase in the level of
homocysteine that causes toxic effect. However, the
development of endothelial dysfunction and reduced
anti-oxidative protection in newborns with 677CT and
677TT genotypes can be considered as two of the most
important mechanisms of realization of unfavorable
impact of polymorphic MTHFR variants in perinatal
period.
Our preliminary analysis showed that the
polymorphic gene variants, studied in this work,  are
the most important for normal course of metabolic
processes in perinatal period. Modifications in
structures of genes and their functional activity are the
key factors in the development of perinatal pathologies
and can assist the reduction of gestation term due to the
accumulation of functional changes throughout
prenatal  development, which decrease the adaptation
of fetus to antenatal life conditions.
Tables 2 and 3 present the results of our analysis of
polymorphic variants of ACE, AT2R1, MTHFR, and
TNF-á genes. Analysis of frequency of polymorphic
variants in premature and mature newborns showed
(Table 2) that reduced gestations terms are reliably
associated only with homozygous variant 677TT of
MTHFR (÷2 = 11.43, OR = 5.66 (1.87-17.1)).
In our previous publication [3] we have shown that  
at all types of perinatal pathologies this genotype was
predominantly (5 to 7 times) present in premature
newborns whereas in the general group of newborns
the increased frequency of 677TT genotype was shown 
to be unreliable, which confirms again the association
of this genotype with reduced gestation term.
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Gene Genotype
Premature patients Mature patients
χ2 OR CI
n % n %
ACE (I/D) II 15 12,61 23 19,83 2,26 1,71 0,84–3,48
ID 69 57,98 60 51,72 0,93 0,78 0,46–1,30
DD 35 29,41 33 28,45 0,03 0,95 0,54–1,68
AT2R1 (A1166C) 1166AA 67 56,30 61 52,58 0,33 0,86 0,51–1,44
1166AC 36 30,25 47 40,52 2,71 1,53 0,92–2,69
1166CC 16 13,45 8 6,90 2,75 0,48 0,20–1,16
TNF-α (G308Α) 308GG 51 42,86 50 43,10 0,00 1,01 0,60–1,69
308GA 55 46,02 59 50,86 0,51 1,20 0,72–2,01
308AA 13 10,92 7 6,03 1,80 0,52 0,20–1,36
MTHFR (C677T) 677CC 48 40,34 49 42,24 0,09 1,08 0,64–1,82
677CT 51 42,86 63 54,31 3,08 1,58 0,95–2,65
677TT 20 16,81 4 3,45 11,43 5,66 1,87–17,1*
*p < 0,05.
Table2
Distribution of genotypes of studied genes in mature and premature newborns
Due to the fact that no statistically significant
differences have been revealed in distribution of
polymorphic variants of ACE, AT2R1, and TNF-á in
mature and premature sick newborns (Table 2), in our
further work the results of genotyping were compared
for the integrated group of all children with perinatal
pathology and the control, while for MTHFR gene an
additional analysis was performed].
Table 3 shows that for all studied polymorphic
variants of ACE, AT2R1, TNF-á, MTHFR, except for
one (677TT genotype of MTHFR gene), we revealed
statistically reliable differences in frequencies of
genotypes, i.e.: 1) increased frequency in the group of
sick (DD, ID of ACE gene; 1166CC, 1166AC of
AT2R1; 677CT of MTHFR; 308AA, 308AG of
TNF-á), which testifies to the association of these
genotypes with increased risk of the development of
perinatal pathologies, in case of homozygotes, the risk
being almost twice as high as that for heterozygotes; 2)
reduced frequency in the sick compared to the control
(II of ACE gene; 1166AA of AT2R1; 677CC of
MTHFR; 308GG of TNF-á), which characterises
protective effect of the aforementioned genotypes.
High reliability of the results obtained confirms the
participation of selected genes in pathogenesis of
severe perinatal pathology.
The separate analysis of the polymorphic variants
of MTHFR gene in mature and premature newborns
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Locus
Patients Control Statistic parameters
n % n % χ2 OR 95 % CI p
ÀÑÅ (I/D)
Genotype
II 38 16,17 51 46,36 35,68 0,22 0,13–0,37  <0,001
ID 129 54,89 44 40,00 6,65 1,83 1,15–2,89 <0,01
DD 68 28,94 15 13,64 9,6 2,58 1,40–4,76 <0,01
AT2R1 (A1166C)
Genotype
1166AA 128 54,47 84 76,36 15,16 0,37 0,22–0,62 <0,01
1166AC 83 35,32 24 21,82 6,38 1,96 1,16–3,31 <0,05
1166CC 24 10,21 2 1,82 7,58 6,14 1,42–26,47 <0,05
MTHFR (C677T)
Genotype
677CC 97 41,28 68 61,82 12,67 0,43 0,27–0,69 <0,05
677CT 114 48,51 37 33,63 6,74 1,86 1,16–2,98 <0,05
677TT 24 10,21 5 4,55 3,13 2,39 0,89–6,44 >0,05
TNF-α (G308A)
Genotype
308GG 101 42,98 80 72,73 16,45 0,28 0,17–0,46 <0,01
308AG 114 48,51 28 25,45 26,59 2,86 1,67–4,55  <0,001
308AA 20 8,51 2 1,82 5,62 5,02 1,15–21,89 <0,05
Table 3
Distribution of frequencies of genotypes by ACE, AT2R1, MTHFR and TNF-á in newborns with perinatal pathology and in control
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Fig. 2 Comparative analysis
of distribu- tion of
frequencies of genotypes for 
stu- died genes: grey –
control; white – newborns
with peri- natal pathology
Genotype
combination
Patients, n = 235 Control, n = 110 Statistic parameters
n % n % χ2 OR 95 % CI p
ACE/TNF-a
ID/AG 75 31,9 13 11,82 15,93 3,5 1,84–6,64 < 0,05
II/GG 31 13,19 42 38,18 28,05 0,25 0,14–0,42 < 0,05
ACE/MTHFR
DD/CT 39 16,6 6 5,45 8,2 3,45 1,41–8,41  < 0,05
ID/CT 59 25,11 17 15,45 4,06 1,83 1,01–3/33  < 0,05
II/CC 20 8,51 37 33,64 34,3 0,18 0,10–0,34    < 0,001
ACE/AT2R1
²²/ÀÀ 13 5,52 50 45,45 56,74 0,07 0,04–0,14   < 0,001
TNF-a/MTHFR
AG/CT 59 25,11 12 10,91 9,24 2,74 1,40–5,34 < 0,05
GG/CC 42 17,87 52 47,27 32,67 0,24 0,14–0,39   < 0,001
TNF-a/AT2R1
AG/AC 35 14,89 7 6,36 5,1 2,58 1,11–6,00  < 0,05
GG/AA 51 21,70 63 57,27 42,85 0,21 0,13–0,34    < 0,001
ACE/AT2R1/MTHFR/TNF-α
²²/ÀÀ/ÑÑ/GG 6 2,55 30 27,27 48,99 0,07 0,03–0,17    < 0,001
Table 4
Analysis of significant combinations of studied genotypes of ACE, AT2R1, MTHFR, and TNF-a genes
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with perinatal pathologies compared with the control
demonstrated that   genotype 677TT had increased
frequency only for premature newborns, 677CT - for
mature newborns, whereas the frequency of 677CC
genotype was reliably decreased equally in mature and
premature newborns. (Noteworthy fact is that generally 
in the group of sick (Table 3) the increase in frequency
of 677TT genotype was unreliable.) It means that the
presence of T-allele in homozygous or heterozygous
condition is also a risk factor in the development of
perinatal pathologies regardless of gestation age.
Fig.2 illustrates revealed by us multidirectional
influence of homozygotes with different allele variants
of each of four genes on the development of perinatal
pathology (unfavorable effect of homozygosis for one
allele and protective - for homozygotes on the other
allele).
We have analyzed all possible combinations of
polymorphic variants of studied genes, and some
combinations were detected in some patients, whereas
the others were not  revealed at all. Table 4 presents
only those combinations of studied genes, the
frequencies of which were reliably different for sick
and healthy newborns.
 Comparison of the  data in Tables 3 and 4 revealed
the presence of potentiating effect of combination of
some polymorphic variants in newborns’ genotypes on
the development of perinatal pathologies: 1) increased
risk for combination  in ID genotype of ACE gene and 
genotype AG of TNF-á gene variant (at the
combination of mentioned polymorphic variants of OR 
increases to 3.5 compared with the presence of only
one of these variants – OR equals 1.83 and 2.86
respectively). The risk increases also for the
combination of  DD variant of ACE gene  and CT
variant of MTHFR gene (OR=3.45 for the combination
of variants against 2.58 and 1.86 respectively for
separate polymorphic variants); 2) significantly
reduced risk of perinatal pathology at the combination
of polymorphic variants with proven by our study
protective action: the most significantly reduced risk
(14.23 times) at the combination II of ACE gene and
AA variants of AT2R1 gene, which finds its
confirmation in decrease in OR down to 0.07 against
0.22 and 0.37 for certain corresponding variants at high 
probability (÷2=56.74, p<0.001) and II of ACE/CC of
MTHFR (5.45 times), GG of gene TNF-á/AA of
AT2R1 (4.84 times), GG of TNF-á/CC of MTHFR
(4.12 times), GG TNF-á/II of ACE (3.97 times).
As it can be seen from Table 4, the maximal
potentiating effect is inherent to the combination II of
ACE/AA variant of AT2R1 as even the increase in the
number of protective homozygous variants up to 4 in
individual genotype has influence neither on the level
of risk (OR=0.07) nor on the degree of reliability
(OR=0.001).
Rating of genotype/phenotype correlation based on 
the results of this study will be presented in a separate
publication.
The results obtained on distribution of
polymorphic variants of investigated genes and their
combinations as well as the results of statistical
analysis testify to the presence of genetic susceptibility
to the development of critical conditions in newborns 
in early prenatal period and reduction of gestation
period.
Genetic susceptibility to perinatal pathology in
newborns, revealed by us, along with subsequent
investigations and developments will accommodate the 
creation of personified protocols of prophylactics and
treatment of critical conditions.
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Öåëü. Èçó ÷èòü àñ ñî öè à öèþ ïî ëè ìîð ôíûõ âà ðè àí òîâ ãå íîâ ACE
(I/D), AT2R1 (A1166C), TNF-α (G308A), MTHFR (C677Ò) è èõ êîì -
áè íà öèé c ðèñ êîì ðàç âè òèÿ ïå ðè íà òàëü íîé ïà òî ëî ãèè è ñî êðà ùå -
íè åì ñðî êîâ ãåñ òà öèè. Ìå òî äû. Ïî ëè ìîð ôíûå âà ðè àí òû ãå íîâ
àíà ëè çè ðî âà ëè ìå òî äà ìè ïî ëè ìå ðàç íîé öåï íîé ðå àê öèè è ïî ëè -
ìîð ôèç ìà äëè íû ðåñ òðèê öè îí íûõ ôðàã ìåí òîâ ó 235 íî âî ðîæ -
äåí íûõ ñ òÿ æå ëîé ïå ðè íà òàëü íîé ïà òî ëî ãè åé è 110 êëè íè ÷åñ êè
çäî ðî âûõ äî íî øåí íûõ íî âî ðîæ äåí íûõ. Ðå çóëü òà òû. Ïîâû- øåí -
íûé ðèñê ðàç âè òèÿ òÿ æå ëîé ïå ðè íà òàëü íîé ïà òî ëî ãèè îá óñëîâ -
ëåí ãå íî òè ïà ìè DD è ID (ACE), 1166AC, 1166ÑÑ (AT2R1), 677ÑÒ
(MTHFR), 308ÀA è 308ÀG (TNF-α), ïðè ÷åì äëÿ ãî ìî çè ãîò îí ïî -
÷òè â 2 ðàçà âûøå, ÷åì äëÿ ãå òå ðî çè ãîò. Ñîê ðà ùå íèå ñðî êîâ ãåñ -
òà öèè ñâÿ çà íî ñ ãå íî òè ïîì 677ÒÒ (MTHFR), à ðå çèñ òåí òíîñòü ê
âîç íèê íî âå íèþ çà áî ëå âà íèé â ïå ðè íà òàëü íîì ïå ðè î äå – ñ ãå íî òè -
ïîì II (ACE) è 1166AA (AT2R1), 677ÑÑ (MTHFR) è 308GG
(TNF-α), îñî áåí íî ïðè èõ ñî ÷å òà íèè. Âû âî äû. Âû ÿâ ëåí íûå àñ ñî -
öè à öèè ñâè äå ò åëüñòâó þò î ðîëè ïî ëè ìîð ôíèõ âà ðè àí òîâ ãå íîâ
ACE, AT2R1 è TNF-α, MTHFR â ðàç âè òèè òÿ æå ëîé ïå ðè íà òàëü -
íîé ïà òî ëî ãèè è ìî ãóò áûòü èñ ïîëü çî âà íû äëÿ ðàí íå ãî ïðî ãíî çè -
ðî âà íèÿ åå âîç íèê íî âå íèÿ ñ ïî ñëå äó þ ùåé êîð ðåê öè åé òàê òè êè
ëå ÷å íèÿ.
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ACE, AT2R1, TNF-α, MTHFR
Í. Ã. Ãî ðî âåí êî, Ñ. Ï. Êèð ’ÿ ÷åí êî, Ç. ². Ðîñ ñî õà
Âèâ ÷åí íÿ àñîö³àö³¿ ïîë³ìîð ôíèõ âàð³àíò³â ãåí³â ACE (I/D), 
AT2R1 (A1166C), TNF-α (G308A), MTHFR (C677Ò) òà 
¿õí³õ êîìá³íàö³é ç ðè çè êîì ðîç âèò êó ïå ðè íà òàëü íî¿ ïà òî ëîã³¿ ³ 
ñêî ðî ÷åí íÿì òåðì³í³â ãåñ òàö³¿ 
Ðå çþ ìå
Ìåòà. Âèâ ÷è òè àñîö³àö³þ ïîë³ìîð ôíèõ âàð³àíò³â ãåí³â ACE (I/D), 
AT2R1 (A1166C), TNF-α (G308A), MTHFR (C677Ò) òà ¿õí³õ êîì-
á³íàö³é ç ðè çè êîì ðîç âèò êó ïå ðè íà òàëü íî¿ ïà òî ëîã³¿ ³ ñêî ðî ÷åí -
íÿì òåðì³í³â ãåñ òàö³¿. Ìå òî äè. Ïîë³ìîðôí³ âàð³àíòè ãåí³â àíà-
ë³çó âà ëè ìå òî äà ìè ïîë³ìå ðàç íî¿ ëàí öþ ãî âî¿ ðå àêö³¿ òà ïîë³ìîð-
ô³çìó äîâ æè íè ðåñ òðèêö³éíèõ ôðàã ìåíò³â ó 235 íî âîíà ðîä æå -
íèõ ç âàæ êîþ ïå ðè íà òàëü íîþ ïà òî ëîã³ºþ òà â 110 êë³í³÷íî çäî -
ðî âèõ äî íî øå íèõ íî âîíà ðîä æå íèõ. Ðå çóëü òà òè. Ï³äâè ùå íèé ðè-
çèê ðîç âèò êó âàæ êî¿ ïå ðè íà òàëü íî¿ ïà òî ëîã³¿ îá óìîâ ëå íèé ãå íî -
òè ïà ìè DD ³ ID (ACE), 1166AC, 1166ÑÑ (AT2R1), 677ÑÒ
(MTHFR), 308ÀA ³ 308ÀG (TNF-α), ïðè ÷î ìó äëÿ ãî ìî çè ãîò â³í
ìàé æå âäâ³÷³ âè ùèé, í³æ äëÿ ãå òå ðî çè ãîò. Ñêî ðî ÷åí íÿ òåðì³í³â
ãåñ òàö³¿ ïî â’ÿ çà íå ç ãå íî òè ïîì 677ÒÒ (MTHFR), à ðåçèñòåíò-
í³ñòü äî âè íèê íåí íÿ çà õâî ðþ âàíü â ïå ðè íà òàëü íî ìó ïåð³îä³ – ç ãå -
íî òè ïîì II (ACE), 1166AA (AT2R1), 677ÑÑ (MTHFR) ³ 308GG
(TNF-α), îñîá ëè âî ïðè ¿õíüî ìó ïîºäíàíí³. Âèñ íîâ êè. Âè ÿâ ëåí³
àñîö³àö³¿ ñâ³ä÷àòü ïðî ðîëü ïîë³ìîð ôíèõ âàð³àíò³â ãåí³â ACE,
AT2R1, TNF-α ³ MTHFR ó ðîç âèò êó âàæ êî¿ ïå ðè íà òàëü íî¿ ïà òî -
ëîã³¿ ³ ìî æóòü áóòè âè êî ðèñ òàí³ äëÿ ðàí íüî ãî ïðî ãíî çó âàí íÿ ¿¿
âè íèê íåí íÿ ç ïîä àëü øèì êî ðè ãó âàí íÿì òàê òè êè ë³êó âàí íÿ.
Êëþ ÷îâ³ ñëî âà: ïå ðè íà òàëü íà ïà òî ëîã³ÿ, ïîë³ìîðô³çì, ãåíè
ACE, AT2R1, TNF-α, MTHFR.
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